PSMA PET/CT in Prostate Cancer: Next-Level Precision at Healthcare International

 

Introduction

At Healthcare International, we offer world-class PSMA PET/CT imaging—an advanced modality that elevates diagnostic accuracy for prostate cancer. By combining molecular targeting with high-resolution imaging, PSMA PET/CT enables early detection, precise treatment planning, and improved outcomes—while preserving quality of life.

---

1. Why PSMA PET/CT is a Game-Changer

• Targeted detection of prostate cancer, even at very low PSA levels—well beyond the capability of traditional imaging.
• Detects pelvic lymph node metastases with ~85% sensitivity (compared to ~38% via conventional bone scans and CT).
• In high-risk cases, early identification of hidden metastases occurred in 28% of patients, significantly altering treatment strategies.
• Plays a key role in radiation therapy planning, enabling accurate targeting for IGRT, SBRT, CyberKnife, and Proton Beam Therapy (PBT).

---

2. Impact on Treatment Decisions

PSMA PET/CT often reveals disease spread that is invisible on standard scans, leading to tailored and more effective care plans:

• In multicentre trials, it shifted treatment from surgery to systemic therapy when required—improving precision and outcomes.
• Enables localized salvage radiotherapy by pinpointing recurrence early—enhancing treatment response while avoiding unnecessary toxicity.
• Facilitates follow-up monitoring to assess treatment response and detect early recurrence, ensuring timely intervention.

---

3. What to Expect from the Scan

• You will receive an injection of a radiolabelled tracer (e.g., Ga-68 PSMA-11 or F-18 piflufolastat/Pylarify) that binds specifically to prostate cancer cells.
• After tracer uptake, a PET/CT scan is performed to generate detailed images of the prostate and any metastatic sites.
• The scan is non-invasive, involves minimal discomfort, and uses a safe, low-dose radiation protocol.

---

4. The Patient Advantage at Healthcare International

• Imaging performed with FDA-approved tracers to ensure optimal accuracy and safety.
• Results interpreted using standardized frameworks like PSMA-RADS for clarity and consistency across our expert teams.
• Findings from PSMA PET/CT are reviewed by our multidisciplinary tumour board, enabling highly personalized treatment planning—from focal radiotherapy and salvage procedures to systemic therapies.

---

5. Summary at a Glance

Feature	PSMA PET/CT at Healthcare International
Detection Sensitivity	Exceptional—even at low PSA; superior to bone scans and CT
Impact on Treatment	Alters strategy in ~28% of high-risk cases
Use Cases	Initial staging, recurrence detection, treatment planning, radiation therapy guidance, follow-up monitoring
Patient Experience	Non-invasive scan, minimal radiation, high diagnostic precision
Decision-Making Power	Enables truly personalized treatment plans

---

6. Patient-Focused Precision

Imagine having a clear map of where cancer exists—even at microscopic levels. At Healthcare International, PSMA PET/CT delivers that clarity, whether you are newly diagnosed, monitoring recurrence, or adapting treatment midway.

We are committed to leveraging this advanced imaging not only to improve survival but also to preserve your quality of life.

📅 Book your PSMA PET/CT scan today—because cancer care should be as precise as it is compassionate.

For more treatment options for prostate cancer, visit healthcareinternational.in